HUTCHMED (China) Limited - American Depositary Shares (HCM)
Healthcare › Pharmaceutical Preparations
Price History
Feb 9, 2026 — May 8, 2026Investment Snapshot
- Trading 35% below Graham Number ($20.45) — significant margin of safety
- Piotroski F-Score 4/9 — moderate financial health
- Strong ROE of 36.9% with 83.3% net margin
- Revenue declining 13% annually
HUTCHMED (China) Limited - American Depositary Shares (HCM) is a Healthcare company operating in Pharmaceutical Preparations, listed on the NASDAQ , with a market capitalisation of $2.3 billion . Key value metrics: P/E ratio 5.1, P/B ratio 1.88, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
HUTCHMED (China) Limited - American Depositary Shares — Fundamental Analysis Summary
HUTCHMED (China) Limited - American Depositary Shares (HCM) is trading 35% below its Graham Number of $20.45 — a significant margin of safety by Benjamin Graham's standard. The stock carries a low trailing P/E ratio of 5.1x.
On financial health, HCM shows a moderate Piotroski F-Score of 4/9, and strong return on equity of 36.9% (sector average: -20.6%), and minimal leverage with a debt-to-equity ratio of 0.10.
StockPik's composite Value Score for HCM is 100/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
HCM reports a moderate gross margin of 38.7% (sector average: 40.1%) and a negative operating margin of -7.1%.
HCM shows revenue declining at 13% year-over-year, with earnings growing at 1,111%.